Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about wegovy
Recent news which mentions wegovy
< Previous
1
2
3
4
Next >
Weight-Loss Drug Ozempic Sparks Frenzy In Cyprus Despite Limited Accessibility
August 27, 2023
Tags
wegovy
cyprus
Market News
From
Benzinga
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
August 25, 2023
Tickers
CTLT
NVO
TMO
Tags
General
NVO
Biotech
From
Benzinga
Novo Nordisk Eyes Social Inequality To Enhance Access To Wegovy: 'Have To Be More Intentional'
August 25, 2023
Tickers
NVO
Tags
wegovy
Market News
Benzinga
From
Benzinga
Darcey Silva Accused Of Using 'Miracle' Drug Ozempic After Showing Dramatic Weight Loss
August 25, 2023
Tags
Benzinga
Novo Nordisk
weightloss
From
Benzinga
Republican Congressman George Santos Shed 92 Pounds With 'Miracle' Weight Loss Drug Ozempic: Report
August 25, 2023
Tags
Politics
Diabetes
weightloss
From
Benzinga
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
August 25, 2023
Tickers
NVO
Tags
Diabetes
NVO
Cardiovascular disease
From
Benzinga
Denmark Mulls Changes To Diabetes Drug Subsidies: A Closer Look At Weight Loss Drug Debate
August 23, 2023
Tickers
NVO
Tags
Health Care
Market News
Government
From
Benzinga
Famed Weight Loss Drugs - Medications Far Pricier In US Than Other Developed Countries
August 18, 2023
Tickers
LLY
NVO
Tags
Health Care
Market News
Large Cap
From
Benzinga
Ozempic Competitor Wegovy Could Prevent 1.5M Heart Attacks And Strokes Over 10 Years, Study Reveals
August 16, 2023
Tickers
NVO
Tags
wegovy
Health Care
Market News
From
Benzinga
Tracy Morgan Credits 'Miracle' Weight Loss Drug Ozempic For Shedding Pounds: 'I Ain't Letting It Go!'
August 15, 2023
Tags
Entertainment
Market News
Health Care
From
Benzinga
Weight-Loss Drugs Ozempic, Wegovy Pose Life-Threatening Risks For Surgery And Anesthesia Patients: Expert Warns
August 13, 2023
Tags
Benzinga
Novo Nordisk
Anesthesia
From
Benzinga
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
August 10, 2023
Tickers
LLY
NVO
Tags
Market News
Equities
wegovy
From
Benzinga
65% Profit On Eli Lilly — 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug — Raising The Target
August 09, 2023
Tickers
CI
CVS
LLY
NVO
Tags
NVO
contributors
CI
From
Benzinga
After This Pharma Stock Surges To Record High, Cramer Says It's 'Going Higher Still'
August 09, 2023
Tickers
LLY
NVO
Tags
Mounjaro
Biotech
News
From
Benzinga
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
August 08, 2023
Tickers
LLY
NVO
Tags
General
Mounjaro
Ozempic
From
Benzinga
'Miracle' Weightloss Drugs Ozempic, Wegovy Can 'Pull The Trigger' For Eating Disorders
August 02, 2023
Tags
wegovy
Market News
Health Care
From
Benzinga
Expert Warns 'Miracle' Weight Loss Drug Ozempic Might Require Lifelong Use: 'Are You Prepared...?'
July 27, 2023
Tags
wegovy
Market News
Health Care
From
Benzinga
Teresa Giudice Under Fire From Fans Over Ozempic And Photoshop Claims: 'Please Be Real'
July 26, 2023
Tags
General
Ozempic
Teresa Giudice
From
Benzinga
Novo Nordisk's Ozempic And Wegovy Under Scrutiny Amid Reports Of 'Stomach Paralysis'
July 25, 2023
Tickers
NVO
Tags
NVO
Diabetes
Health Care
From
Benzinga
Novo Nordisk's Obesity Drug Shortage: Crunch Expands To First Gen Med Saxenda Amid Increased Demand
July 20, 2023
Tickers
NVO
Tags
Benzinga
Briefs
NVO
From
Benzinga
TikTok Cracks Down On Health Influencers Amid Growing Popularity Of 'Miracle' Weight Loss Drug Ozempic
July 19, 2023
Tags
General
influencers
Ozempic
From
Benzinga
Shortage Of Elon Musk-Popularized 'Miracle' Weight-Loss Drug Puts Diabetic Patients In Peril, Regulator Warns
July 18, 2023
Tags
Health Care
Department of Health
Media
From
Benzinga
Despite Backlash, 'Real Housewives' Star Dolores Catania Talks About Using Ozempic: 'I'm Being Realistic'
July 17, 2023
Tags
Biotech
News
Ozempic
From
Benzinga
Kim Kardashian And Sharon Osbourne's Influence Leads To Ozempic-Inspired Dishes In Hollywood Restaurants
July 17, 2023
Tags
General
Ozempic
Elon Musk
From
Benzinga
Lisa Marie Presley's Autopsy Prompts Expert To Warn About 'Miracle' Weight Loss Drug Ozempic: 'Nobody's Talking About This'
July 16, 2023
Tags
Lisa Marie Presley
Market News
Health Care
From
Benzinga
Amy Schumer Says 'Felt So Sick' After Using Weight Loss Drug: 'Everyone's Lying...Shut The F**k Up. You Are On Ozempic'
July 13, 2023
Tags
Health Care
Media
Diabetes
From
Benzinga
Raven-Symoné Criticizes Hollywood's Misuse Of Ozempic For 'Glamazon' Purposes: 'Save Some Medication For The People That Actually Need It'
July 13, 2023
Tags
Health Care
Entertainment
Diabetes
From
Benzinga
'Ozempic Butt:' TikTok User Says 'Nothing To Brag About' After Popular Weight Loss Drug Leaves Her With Saggy Skin
July 13, 2023
Tags
Market News
wegovy
General
From
Benzinga
Beware! Ozempic Has A Doppleganger And It Can Be Dangerous
July 12, 2023
Tickers
NVO
Tags
lawsuit
semaglutide
Media
From
Benzinga
'Miracle' Weight Loss Durg Ozempic's Has A Counterfeit In The Market – But It Has 'Life-Threatening' Consequences, Swiss Regulator Warns
July 12, 2023
Tags
Market News
Swissmedic
wegovy
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.